Literature DB >> 10446963

Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.

M C Curia1, R Palmirotta, G Aceto, L Messerini, M C Verì, S Crognale, R Valanzano, F Ficari, P Fracasso, V Stigliano, F Tonelli, V Casale, F Guadagni, P Battista, R Mariani-Costantini, A Cama.   

Abstract

We analyzed the hMLH1 and hMSH2 genes in 30 unrelated hereditary nonpolyposis colorectal cancer (HNPCC) patients using mutational and immunohistochemical analyses combined whenever possible with primer extension assays, designed to estimate hMLH1 and hMSH2 transcript expression in peripheral blood lymphocytes. Single-strand conformational polymorphism screening and PCR-direct sequencing revealed seven hMLH1 and five hMSH2 sequence variants in 14 unrelated HNPCC patients, including three definite pathogenic mutations, four amino acid substitutions of uncertain pathogenic significance, and five polymorphisms. Immunohistochemistry indicated the lack of either hMLH1 or hMSH2 protein expression in tumors from 13 patients, and the absence of both hMLH1 and hMSH2 immunostaining was observed in the tumor from one additional case. The lack of hMLH1 or hMSH2 immunostaining was associated with the presence of microsatellite instability in the corresponding tumor and was also observed in tumors from patients negative for pathogenic mutations by mutational screening. There was a marked unbalance in the allelic expression of either hMLH1 or hMSH2 transcripts in three of eight unrelated HNPCC patients that could be analyzed, although a less marked unbalance was detected in two additional patients. Tumors from patients with germ-line unbalance in hMLH1 or hMSH2 transcript expression did not express the corresponding mismatch repair protein and displayed microsatellite instability. Our results indicate that constitutional alterations in hMLH1 and hMSH2 transcript expression may represent genetic markers for HNPCC carrier status also in cases in which mutational analysis did not detect a definite pathogenic variant. This suggests that transcript deregulation may represent a relevant mode of germ-line inactivation for mismatch repair genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446963

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.

Authors:  A Brieger; J Trojan; J Raedle; G Plotz; S Zeuzem
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.

Authors:  J Tinat; S Baert-Desurmont; J B Latouche; S Vasseur; C Martin; E Bouvignies; T Frébourg
Journal:  Fam Cancer       Date:  2008-05-22       Impact factor: 2.375

4.  Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.

Authors:  R E Wilentz; M Goggins; M Redston; V A Marcus; N V Adsay; T A Sohn; S S Kadkol; C J Yeo; M Choti; M Zahurak; K Johnson; M Tascilar; G J Offerhaus; R H Hruban; S E Kern
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

5.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

6.  The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

Authors:  Davide Rossi; Alessio Bruscaggin; Piera La Cava; Sara Galimberti; Elena Ciabatti; Stefano Luminari; Luigi Rigacci; Alessandra Tucci; Alessandro Pulsoni; Giovanni Bertoldero; Daniele Vallisa; Chiara Rusconi; Michele Spina; Luca Arcaini; Francesco Angrilli; Caterina Stelitano; Francesco Merli; Gianluca Gaidano; Massimo Federico; Giuseppe A Palumbo
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

7.  Mismatch repair protein expression in colorectal cancer.

Authors:  Elrasheid A H Kheirelseid; Nicola Miller; Kah Hoong Chang; Catherine Curran; Emer Hennessey; Margaret Sheehan; Michael J Kerin
Journal:  J Gastrointest Oncol       Date:  2013-12

8.  Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients.

Authors:  Jin C Kim; Seon A Roh; Kum H Koo; In H Ka; Hee C Kim; Chang S Yu; Kang H Lee; Jung S Kim; Han I Lee; Walter F Bodmer
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

9.  Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing.

Authors:  Raffaele Palmirotta; Sabino Matera; Maria Cristina Curia; Gitana Aceto; Bassam el Zhobi; Fabio Verginelli; Fiorella Guadagni; Vincenzo Casale; Vittoria Stigliano; Luca Messerini; Renato Mariani-Costantini; Pasquale Battista; Alessandro Cama
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

10.  Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.

Authors:  Yvonne Hendriks; Patrick Franken; Jan Willem Dierssen; Wiljo De Leeuw; Juul Wijnen; Enno Dreef; Carli Tops; Martijn Breuning; Annette Bröcker-Vriends; Hans Vasen; Riccardo Fodde; Hans Morreau
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.